Insights

Strategic Partnerships SpringWorks Therapeutics secured a $75 million equity investment from GlaxoSmithKline, indicating potential collaboration and sales opportunities with a major player in the industry.

Expansion Opportunities The recent launch of a New Drug Application and initiation of Marketing Authorization Application in the US and Europe demonstrate potential avenues for sales expansion and market penetration for SpringWorks Therapeutics.

Market Entry Success Going public and announcing positive trial results indicate strong market entry for SpringWorks Therapeutics, presenting an opportune moment for sales activity and growth.

Top Talent Acquisition Steering SpringWorks' scientific efforts, the appointment of Dr. Tai-An Lin as Chief Scientific Officer and the hiring of Dr. Lin as Senior VP, brings in expertise that can drive innovation and sales success.

Competitive Landscape Analysis Analyzing similar biotech companies like Schrödinger and Deciphera Pharmaceuticals provides insights into market trends, competitive positioning, and potential collaboration or differentiation strategies for SpringWorks Therapeutics.

SpringWorks Therapeutics Tech Stack

SpringWorks Therapeutics uses 8 technology products and services including SAS/STAT, WordPress, Kentico, and more. Explore SpringWorks Therapeutics's tech stack below.

  • SAS/STAT
    Advanced Analytics And Data Science
  • WordPress
    Content Management System
  • Kentico
    Content Management System
  • Veeva Vault
    Enterprise Content Management
  • Microsoft Dynamics GP
    Enterprise Resource Planning
  • OWL Carousel
    Javascript Libraries
  • Slick
    Javascript Libraries
  • Linux
    Programming Languages

Media & News

SpringWorks Therapeutics's Email Address Formats

SpringWorks Therapeutics uses at least 1 format(s):
SpringWorks Therapeutics Email FormatsExamplePercentage
flast@springworkstx.comJDoe@springworkstx.com
77%
first.last@springworkstx.comJohn.Doe@springworkstx.com
16%
last@springworkstx.comDoe@springworkstx.com
5%
firstlast@springworkstx.comJohnDoe@springworkstx.com
2%

Frequently Asked Questions

Where is SpringWorks Therapeutics's headquarters located?

Minus sign iconPlus sign icon
SpringWorks Therapeutics's main headquarters is located at 100 Washington Blvd Stamford, Connecticut 06902 US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is SpringWorks Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact SpringWorks Therapeutics's main corporate office by phone at +1-646-661-7451. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is SpringWorks Therapeutics's stock symbol?

Minus sign iconPlus sign icon
SpringWorks Therapeutics is a publicly traded company; the company's stock symbol is SWTX.

What is SpringWorks Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
SpringWorks Therapeutics's official website is springworkstx.com and has social profiles on LinkedIn.

How much revenue does SpringWorks Therapeutics generate?

Minus sign iconPlus sign icon
As of May 2024, SpringWorks Therapeutics's annual revenue reached $75M.

What is SpringWorks Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
SpringWorks Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does SpringWorks Therapeutics have currently?

Minus sign iconPlus sign icon
As of May 2024, SpringWorks Therapeutics has approximately 314 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: S. I.Chief Executive Officer: S. I.Chief Executive Officer: K. M.. Explore SpringWorks Therapeutics's employee directory with LeadIQ.

What industry does SpringWorks Therapeutics belong to?

Minus sign iconPlus sign icon
SpringWorks Therapeutics operates in the Biotechnology Research industry.

What technology does SpringWorks Therapeutics use?

Minus sign iconPlus sign icon
SpringWorks Therapeutics's tech stack includes SAS/STATWordPressKenticoVeeva VaultMicrosoft Dynamics GPOWL CarouselSlickLinux.

What is SpringWorks Therapeutics's email format?

Minus sign iconPlus sign icon
SpringWorks Therapeutics's email format typically follows the pattern of . Find more SpringWorks Therapeutics email formats with LeadIQ.

How much funding has SpringWorks Therapeutics raised to date?

Minus sign iconPlus sign icon
As of May 2024, SpringWorks Therapeutics has raised $275M in funding. The last funding round occurred on Dec 05, 2023.

When was SpringWorks Therapeutics founded?

Minus sign iconPlus sign icon
SpringWorks Therapeutics was founded in 2017.
SpringWorks Therapeutics

SpringWorks Therapeutics

Biotechnology ResearchConnecticut, United States201-500 Employees

SpringWorks is a commercial-stage biopharmaceutical company applying a precision medicine approach to developing and delivering life-changing medicines for people with severe rare diseases and cancer.

Founded in 2017, SpringWorks has a diversified targeted oncology pipeline spanning solid tumors and hematological cancers, including clinical trials in rare tumor types and highly prevalent, genetically defined cancers.

Section iconCompany Overview

Headquarters
100 Washington Blvd Stamford, Connecticut 06902 US
Phone number
+1-646-661-7451
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
SWTX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
201-500

Section iconFunding & Financials

  • $275M

    SpringWorks Therapeutics has raised a total of $275M of funding over 5 rounds. Their latest funding round was raised on Dec 05, 2023.

  • $50M$100M

    SpringWorks Therapeutics's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $275M

    SpringWorks Therapeutics has raised a total of $275M of funding over 5 rounds. Their latest funding round was raised on Dec 05, 2023.

  • $50M$100M

    SpringWorks Therapeutics's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.